Drug Formulary Review Archives – April 1, 2003
April 1, 2003
View Issues
-
Bush renews call for Medicare prescription drug card
The Bush administration may have failed in two attempts to offer a prescription drug discount plan, but that wont stop it from trying again. -
Final HIPAA security standards released
The final security standards and transaction modifications for electronic health information are here at last. -
Make an impact on the public’s health
Pharmacists are experts at dispensing the correct drug in the correct dosage to the correct patient. Two pharmacists, however, suggest that the profession can do a better job of considering the public, collectively, as a patient. -
Warfarin prevents recurrence of blood clots
A study of long-term, low-dose warfarin (Coumadin) in the prevention of blood-clotting disorders showed such promise that the National Institutes of Health, the trials sponsor, stopped the study early. -
News Briefs
HHS proposes smallpox vaccination compensation; Counterfeit epoetin alfa presents hazard to patients; Adverse events associated with sirolimus (Rapamune); FDA proposes standards for dietary supplements; APhA releases patient, pharmacist publications. -
New FDA Approvals
The FDA has approved pyridostigmine bromide to increase survival after Soman nerve gas poisoning, which causes loss of muscle control and death from respiratory failure. The product is approved for combat use by United States military personnel. -
Drug Criteria and Outcomes: Voriconazole formulary evaluation
Voriconazole is a new broad-spectrum triazole antifungal. Other drugs in the triazole class are fluconazole and itraconazole.